Home' Spa and Clinic : Volume 59 November 2014 Contents MEDI CLINIC
to use any form of HRT, and non-hormone
lubricants are frequently reported to be
New non-invasive laser technology is
poised to stop the ‘silent epidemic’ in its
tracks, offering straightforward, in-clinic
treatments that take less than 30 minutes
and have minimal downtime and side
effects. Results are reported to be quick
At this stage they are targeted for use
by gynaecologists and plastic/cosmetic
surgeons. However, as we’ve said, clients
often form confidante-type relationships
with trusted therapists and so to be armed
with knowledge of breakthroughs that
have the potential to change lives further
enforces your credibility.
The first of these lasers on the market
in Australia was the MonaLisaTouch,
distributed by High Tech Laser. It
counteracts the effects of vaginal atrophy
with a simple 10-minute treatment.
The V2LR (Vulvo-Vaginal Laser
Reshaping) laser that delivers the
MonaLisaTouch treatment uses a
sophisticated laser emission technology to
deliver microscopic beams of laser light to
the vaginal walls.
This stimulates collagen formation
underneath the vaginal skin, promotes
proliferation of the cells and restoration of
vaginal wall strength and blood supply.
In as little as 30 days after treatment the
regeneration of new tissue in the vaginal
walls builds a naturally stronger structure
and the protective mucosa recovers volume,
hydration and elasticity.
By restoring the natural pH balance
of the vaginal mucosa, and targeting the
causes of vaginal atrophy, many of the
symptoms such as vaginal dryness, laxity,
irritation and fissuring are greatly reduced
or disappear – all with virtually no side
effects or discomfort.
In addition, improvements in the
structure and positioning of the vagina
mean that some external surgical procedures
such as labiaplasty and vaginaplasty may be
avoided in mild to moderate cases.
The inspiration came from the
Smartxide DOT Therapy laser that has
been used for many years for effective anti-
ageing treatments on delicate areas such as
the face, eyes and neck.
Recently introduced to Australia
is Lutronic’s Action II Petit Lady, the
brainchild of Dr Glen Calderhead and
distributed by Advanced Cosmeceuticals.
Lutronic says the laser tightens vaginal
tissues, remodels collagen and rejuvenates
the vulva to revive the sensations while
revitalising the tissues of the vagina, thereby
facilitating more or renewed lubrication.
Action II Petit Lady has already been
successful in both Asia and the Middle East.
In clinical trials conducted in South Korea
(where it was developed) and Japan, the
benefits for menopausal women suffering
acute vaginal atrophy and dryness have
proved to be dramatic.
In Australia to introduce the
revolutionary device and speak at the
A5M Anti-Ageing and Aesthetic Medicine
Conference in Melbourne in August, Dr
Calderhead noted the strong interest shown
in Petit Lady.
“Clinicians have been looking for a
better minimally or non-invasive solution
to vaginal problems that prov ides short
downtimes and low risk of side effects, such
as pain or bleeding,” he says.
“The Action II Petit Lady is non-surgical,
non-invasive and easy to perform. It enables
a practitioner to effectively treat a wide
range of vulva-vaginal symptoms and
“Results can be seen almost immediately
but three treatments are usually
recommended for optimum effect. To date
the results have been lasting.”
Dr Calderhead says that, unlike after
gynaecological surgery, there is no need
to abstain from sex after a Petit Lady
treatment because there is no recovery
time as such. “ We do recommend patients
wait until the day after treatment,” he says.
“However, they are then actively encouraged
to have sex to help promote the benefits of
The original Action II technology
is an Erbium YAG laser used to treat
dermatological issues such as scars,
epidermal benign disorder and epidermal
pigment lesions. It aims to treat the target
area with micron-level precision and
ver y little thermal conduction – so is as
comfortable as possible for the patient.
“Over time it became obvious to us
that it had potential for gy naecological
application,” says Dr Calderhead. “That was
the genesis of Action II Petit Lady.”
To perform the intra-vaginal treatment,
a gold-plated ‘cage’ is first inserted and the
laser handpiece is fitted into that. Patients
have reported experiencing a sensation
of warmth, but no pain. The treatment is
completed in around 15 minutes.
“We have now treated hundreds of
patients with Action II Petit Lady who are
delighted with their outcomes,” he says. “ We
are not only treating their vaginal problems
but in many cases their most important
intimate relationships. That aspect of the
Petit Lady cannot be underestimated.”
IT’S IN THE BLOOD
It was mature women’s problems with and
insecurities about their gy naecological
makeup that took internationally-
recognised cosmetic nurse injector Nicole
Belle, co -owner of Face Today clinics in
Sydney and Cairns, into a revolutionary new
sphere of injecting.
She was the first in Australia asked to
trial Regen PRP (a leading brand offering
Platelet Rich Plasma therapy, distributed by
Australasian Medical and Scientific) for its
skin rejuvenation and healing properties.
PRP is the name given to blood
plasma with a high concentration of
platelets. For the purposes of cosmetic
rejuvenation, the g rowth factors released
New laser and injectable cosmetic
gynaecology therapies are transforming lives
82 | SPA+CLINIC
SC Vol59 p068-105.indd 82
15/10/2014 3:37 pm
Links Archive Volume 60 February 2015 Navigation Previous Page Next Page